ICS 2022 - International Continence Society

Viewing 1-12 of 12 articles

ICS 2022: An Open, Single-Arm, Post-Market Clinical Trial Using The Tena Smartcare Change Indicator™ In A Home Environment.

ICS 2022: Development Of A Conceptual Framework And Digital Platform For The Selfmanagement Of Interstitial Cystitis: Erica (Remote Engagement With Interstitial Cystitis Aide)

ICS 2022: Compliance With Uresta (Cure) Study; A 12 Month Follow-Up Of 40 Women

ICS 2022: A Short Story In Proprioceptive Facilitation To The Pelvic Floor – A Proof Of Concept Study Using INNOVO

ICS 2022: The Impact Of Prevalent Overactive Bladder Anticholinergic Use On Cognitive Change In Adults With Normal Cognition, Mild Cognitive Impairment, Or Dementia

ICS 2022: Efficacy And Safety Of A Novel Gene Therapy (URO-902; PVAX/HSLO) In Female Patients With Overactive Bladder Syndrome And Urgency Urinary Incontinence: Results From A Phase 2a Trial

ICS 2022: Zoom To Scale? Real World Implementation Of Online Versus In-Person Community-Based Continence Promotion

ICS 2022: A Pressure Sensor Array Can Be Used To Show Maximal Pelvic Floor Muscle Contraction In Different Postures

ICS 2022: Effective Pelvic Floor Muscle Exercises In Antenatal Care: Design And Development Of A Training Package For Community Midwives In The United Kingdom

ICS 2022: Prospective Multi Center Registry For Patients Undergoing Surgery For Male Stress Urinary Incontinence (Saturn): 1 Year Follow-Up In 500 Patients

ICS 2022: A Randomised Controlled Trial Of The Clinical And Cost‐Effectiveness Of Vaginal Pessary Self‐Management Vs Clinic-Based Care For Pelvic Organ Prolapse

ICS 2022: Long-Term Results Of App-Based Self-Management Of Urgency And Mixed Urinary Incontinence In Women

email news signup